We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site

IsoPlexis' Unique and Predictive Biology

Learn how to use fully autommated Functional Multi-Omics & Single-Cell Proteomics to accelerate research and medicine.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this we discuss:

Single-cell proteomics reveals immune persistence in cutting-edge CAR-T therapies
Single-cell proteomics informs targeted combination therapies to resolve tumor heterogeneity & overcome resistance
Independent resistance trajectories revealed by single-cell intracellular proteomics & multi-omic characterization
Overcoming the limitations of genomics using single-cell proteomics
A Deeper Look

More about this

Accelerating Predictive Insights into Translation Research

IsoPlexis offers the only technology capable to fully characterize cellular function and how it pertains to patient outcomes such as antitumor response or disease progression.

Download this eBook to learn how it works and review published studies.

Get the